Abstract
Introduction. Some kind of migraine has been prove the existence of cortical hyperexcitability and abnormal brain energy metabolism probably due to mitochondrial dysfunction. In these patients is high suspicion of mutations in mitochondrial DNA that are implicated as pathophysiologic mechanisms in this entity.
Objective. To identify the A3243G mutation of mitochondrial DNA in patients with complications of migraine, sporadic hemiplegic migraine, basilar type migraine, retinal migraine.
Materials and Methods. . A prospective descriptive study of a series of neurological patients in an outpatient of the city of Medellin, with a diagnosis of that subtypes, from August 2006 to December 2007.
Results. The study included 19 patients, 14 women and 5 men with mean age 33.4 ± 13.54 years. Of the different subtypes hemiplegic was the most prevalent (11 patients), followed by basilar migraine (3 patients), migraine status (2 patients), retinal migraine (2 patients) and prolonged aura (1 patient). The A3243G mutation in the DNA of peripheral blood leukocytes, which was only evaluated in the study, was not present in any of the samples.
Conclusions. The mitochondrial DNA A3243G mutation is not related to the presentation of different subtypes in the population studied. Future clinical trials, with a representative number of patients for each subtypes, may draw conclusions about whether the mitochondrial dysfunction caused by this and other mutations associated with the clinical presentation of this type of migraine.
References
Headache Classification Subcommittee of the International headache Society. The International Classification of Headache Disorders 2a edition. Cephalalgia 2004; 24(supl. 1): 8-152.
The International Classification of Headache Disorders. Cephalalgia 1988; 8 (Supl. 7):1-96.
Sparaco M, Feleppa M, Lipton RB, Rapoport AM, Bigal ME. Mitochondrial dysfunction and migraine: evidence and hypotheses. Cephalalgia 2005; 26: 361 -372.
Heddi A, Stepien GM, Benke PJ, Wallace DC. Coordinate induction of energy gene expression in tissues of mitochondrial diseases patients. J Biol Chemistry 1999; 274: 22968-22976.
Buzzi M, Di Gennaro G, D'Onofrio M, Ciccarelli O, Santorelli F, Fortini D et al. ADNmt A3243G MELAS mutation is not associated with multigenerational female migraine. Neurology 2000; 54(4): 1005-1007.
Farrel MA, Brett FM, Droogan O, Murphy S, Burke M, McEntagart M. Family tree phenotype, based on clinical history and mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS) in a Donegal Kindred-clinical and molecular genetics analysis. Irish Medical Journal 1997; 90(4).
Rossignol R, Malgat M, Mazat JP, Thierry Letellier T. Threshold effect and tissue specificity: implication for mitochondrial cytopathies. J Biol Chemistry 1999; 274: 33426-33432.
Galán-Ortega A, Coll-Canti J, Padrós-Fluvià A, Arambarri-Hervias M, Pintos G. Estrategias diagnósticas de las enfermedades mitocondriales. Rev Neurol 1999; 29: 52-58.
Chinnery PF, Howell N, Andrews RM, Turnbull DM. Clinical mitochondrial genetics. J Med Genet 1999; 36: 425-436.
Montagna P, Cortelli P, Barbiroli B. A case of cluster headache associated with mitochondrial DNA deletions. Muscle Nerve 1998; 1(1): 127-129.
Di Gennaro G, Buzzi MG, Ciccarelli O, Santorelli FM, Pierelli F, Fortini D, D'Onofrio M et al. Assessing the relative incidence of mitochondrial DNA A3243G in migraine without aura with maternal inheritance. Headache 2000; 40(7): 568-571.
Goto Y, Horai S, Matsuoka T, Koga Y, Nihei K, Kobayashi M et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): a correlative study of the clinical features and mitochondrial DNA mutation. Neurology 1992; 42: 545-550.
Finnilä S. Detection of mutations in patients with occipital stroke. In: Oulu University Library, editor. Phylogenetic analysis of mitochondrial DNA. Oulu: 2000; p. 1-71.
Jacobs HT, Holt IJ. The np 3243 MELAS mutation: damned if you aminoacylate, damned if you don't. Hum Mol Genet 2000; 9(4): 463-465.
Finnila S, Autere J, Lehtovirta M, Hartikainen P, Mannermaa A, Soininen H, Majamaa K. Increased risk of sensorineural hearing loss and migraine in patients with a rare mitochondrial DNA variant 4336A>G in trNAGln. J Med Genet 2001; 38(6): 400-405.
Rozen TD, Shanske S, Otaegui D, Lu J, Young WB, Bradley K, DiMauro S et al. Study of mitochondrial DNA mutations in patients with migraine with prolonged aura. Headache 2004; 44(7): 674-677.
Parra M, Cornejo W, Carrizosa J, Bedoya G, Ruiz A. Características clínicas y moleculares en dos familias colombianas con la mutación A3243G (MELAS) del ADNmt. [En fase de publicación].
Ciafaloni E, Ricci E, Shanske S et al. MELAS: clinical features, biochemistry, and molecular genetics. Ann Neurol 1992; 31: 391-398.
Cortelli P, Zacchini A, Barboni P, Malpassi P, Carelli V, Montagna P. Lack of association between mitochondrial trNA Leu(UUr) point mutation and cluster headache. Lancet 1995; 345: 1120-1121.
Uncini A, Lodi R, Di Muzio A, Silvestri G, Servirei S, Lugaresi A et al. Abnormal brain and muscle energy metabolism shown by 31P-MRS in familial hemiplegic migraine. J Neurol Sci 1995; 129: 214-222.
Klopstock T, May A, Seibel P, Papagiannuli E, Diener HC, Reichmann H. Mitochondrial DNA in migraine with aura. Neurology 1996; 46: 1735-1738.
Buzzi MG, Di Gennaro G, D'Onofrio M, Ciccarelli O, Santorelli FM, Fortini D et al. MtDNA A3243G MELAS mutation is not associated with multigenerational female migraine. Neurology 2000; 54: 1005-1007.
Di Gennaro G, Buzzi MG, Ciccarelli O, Santorelli FM, Pierelli F, Fortini D et al. Assessing the relative incidence of mitochondrial DNA A3243G in migraine without aura with maternal inheritance. Headache 2000; 40: 568-571.
Grosberg BM, Solomon S, Friedman DI, Lipton RB. Retinal migraine reappraised. Cephalalgia 2006; 26: 1275-1286.
Bousser MG, Welch KM. Relation between migraine and stroke. Lancet Neurol 2005; 4: 533-542.
Ziegler D, Batnitzky S, Barter R, McMillan JH. Magnetic resonance imaging abnormalities in migraine with aura. Cephalalgia 1991; 11: 147-150.
Osborn RE, Alder DC, Mitchell CS. Mr imaging of the brain in patients with migraine headaches. Am J Neuroradiol 2003; 12: 521-524.
Henrich J, Sandercock P, Warlow C, Jones L. Stroke and migraine in the Oxfordshire Community Stroke Project. J Neurol 1986; 233: 257-262.
Etminan M, Takkouche B, Isorna FC, Samii A. Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ 2005; 330: 63-65.
Agostoni E, Fumagalli L, Santoro P, Ferrarese C. Migraine and stroke. Neurol Sci 2004; 25: S123-125.
Mateo I, Foncea N, Vicente I, Gómez M, García-Monco JC. Migraine-associated seizures with recurrent and reversible magnetic resonance imaging abnormalities. Headache 2004; 44(3): 265-270.
Ter Berg HW. Migraine-associated seizure: a case of reversible MrI abnormalities and persistent nondominant hemisphere syndrome. Headache 2001; 41: 326-328.
Thomsen L, Olesen J. Sporadic hemiplegic migraine. Cephalalgia 2004; 24: 1016-1023.
Thomsen L, Ostergaard E, Olesen J, Russell MB. Evidence for a separate type of migraine with aura: sporadic hemiplegic migraine. Neurology 2003; 60: 595-601.
Stang TE, Osterhaus JT. Impact of migraine in the United States: data from national health interview survey. Headache 1992; 33: 29-35.
Osterhaus JT, Gutterman DL, Plachetka JR. Health care resource and lost labor: cost of migraine headache in the United States. PharmacoEconomics 1992; 2: 67-76.
Mathew NT. Pathophysiology, Epidemiology, and Impact of Migraine. Clinical Cornerstone 2001; 4(3): 1-17.
D'Onofrio F, Cologno D, Petretta V, Casucci G, Bussone G. Basilar Type migraine responsive to lamotrigine: Three case reports. Neurol Sci 2007; 28: S239-S241.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.